UBS O'Connor’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $725K | Buy |
55,292
+15,278
| +38% | +$200K | 0.04% | 229 |
|
|
2025
Q1 | $880K | Buy |
+40,014
| New | +$880K | 0.03% | 186 |
|
|
2024
Q4 | – | Sell |
-20,000
| Closed | -$534K | – | 400 |
|
|
2024
Q3 | $534K | Sell |
20,000
-65,008
| -76% | -$1.74M | 0.01% | 329 |
|
|
2024
Q2 | $1.53M | Buy |
85,008
+9,911
| +13% | +$178K | 0.04% | 231 |
|
|
2024
Q1 | $1.37M | Sell |
75,097
-39,588
| -35% | -$722K | 0.04% | 239 |
|
|
2023
Q4 | $1.25M | Sell |
114,685
-25,173
| -18% | -$275K | 0.04% | 242 |
|
|
2023
Q3 | $801K | Hold |
139,858
| – | – | 0.01% | 344 |
|
|
2023
Q2 | $1.08M | Buy |
139,858
+6,890
| +5% | +$53.4K | 0.02% | 370 |
|
|
2023
Q1 | $887K | Buy |
+132,968
| New | +$887K | 0.02% | 418 |
|
|
2022
Q4 | – | Sell |
-110,750
| Closed | -$1.09M | – | 113 |
|
|
2022
Q3 | $1.09M | Sell |
110,750
-14,250
| -11% | -$140K | 0.01% | 727 |
|
|
2022
Q2 | $995K | Buy |
+125,000
| New | +$995K | 0.01% | 755 |
|